Vivitonin Tablets for dogs POM-V

Product Description

Vivitonin® 50 mg tablets
Vivitonin® 100 mg tablets

Species:Dogs

Therapeutic indication:Pharmaceuticals: Cardiovascular and respiratory preparations

Active ingredient:Propentofylline

Product:Vivitonin® 50 mg tablets and Vivitonin® 100 mg tablets

Product index:Vivitonin® 50 mg and 100 mg tablets

Clinical particulars

Target Species

Dogs.

Indications for use

For improvement in dullness, lethargy and overall demeanour in dogs. The veterinary medicinal product is particularly useful in older dogs, where it may increase willingness to exercise and exercise tolerance.

Contraindications

Do not administer to pregnant bitches or breeding animals.

Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

Special warnings for each target species

None.

Special precautions for use

Specific diseases (e.g. kidney disease) should be treated accordingly.

In the case of renal failure, the dose should be reduced.

Consideration should be given to rationalising the medication of dogs already receiving treatment for congestive heart failure or bronchial disease.

Operator warnings

Care should be taken to avoid accidental ingestion.

Wash hands after use.

Adverse Reactions

Dogs:

1Particularly at the commencement of therapy.
2 Necessitates discontinuation of treatment.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.

Use during pregnancy or lactation

Pregnancy:

Do not use in pregnant bitches. The safety of the veterinary medicinal product has not been established during pregnancy.

Fertility:

Do not use in breeding animals.

Interactions

None known.

Amounts to be administered and administration route

Vivitonin 50 mg tablets:

Oral use.

Half a tablet per 5 kg bodyweight twice a day (equivalent to 6-10 mg propentofylline per kg bodyweight per day).

Dogs of less than 5 kg may receive a quarter of a tablet twice a day. Dogs of more than 20 kg can be given Vivitonin 100 mg tablets.

The tablets can be administered directly onto the back of the dog's tongue or can be mixed in a small ball of food and should be administered at least 30 minutes before feeding.

Divide the tablets in halves and quarters with a knife or with a tablet splitter.

Vivitonin 100 mg tablets:

Oral use.

Half a tablet per 10 kg body weight twice a day.

The 100 mg tablets should not be quartered. More accurate dosing may be achieved using a combination of Vivitonin 100 mg and Vivitonin 50 mg tablets. Dogs of less than 20 kg can be given Vivitonin 50 mg tablets.

The tablets can be administered directly onto the back of the dog's tongue or can be mixed in a small ball of food and should be administered at least 30 minutes before feeding.

Divide the tablets in halves with a knife or with a tablet splitter.

Overdose

Symptoms of cardiac and cerebral overstimulation have been observed. In such

cases, animals should be treated symptomatically.

Withdrawal periods

Not applicable.

View other products in Heart »